Epilepsy
📧 Sign up to get email alerts when something new happens for Epilepsy.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2009-11-13FDA Approved: LEVETIRACETAM — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved a supplemental application for a generic formulation of levetiracetam by Torrent Pharmaceuticals Limited.
-
FDA approval · 2009-11-12FDA Approved: LEVETIRACETAM — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved a supplemental application for LEVETIRACETAM from Lupin Pharmaceuticals, marking approval of a generic levetiracetam product.
-
FDA approval · 2009-11-05FDA Approved: LEVETIRACETAM — Supplemental Application (Torrent Pharmaceuticals Limited)
The FDA approves a supplemental application for levetiracetam from Torrent Pharmaceuticals Limited under an ANDA.
-
FDA approval · 2009-11-04FDA Approved: EPITOL — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for EPITOL (carbamazepine) from Teva Pharmaceuticals USA, Inc. The document does not specify the cha…
-
FDA approval · 2009-11-04FDA Approved: LAMOTRIGINE — Original Application (Aurobindo Pharma Limited)
FDA approved a new generic lamotrigine product from Aurobindo Pharma Limited under an Original Application (ANDA).
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2009-11-02FDA Approved: LEVETIRACETAM — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for levetiracetam submitted by Mylan Pharmaceuticals Inc. (ANDA 076919).
-
FDA approval · 2009-10-27FDA Approved: LEVETIRACETAM — Original Application (Amneal Pharmaceuticals LLC)
The FDA approved Amneal Pharmaceuticals' generic levetiracetam via an original application, enabling a generic version of the anti-seizure m…
-
FDA approval · 2009-10-15FDA Approved: CLONAZEPAM — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for a clonazepam generic product from Aurobindo Pharma Limited.
-
FDA approval · 2009-10-14FDA Approved: TOPIRAMATE — Original Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved an original ANDA for Topiramate Sprinkle from Heritage Pharmaceuticals (d/b/a Avet), a generic version of topiramate. It is ind…
-
FDA approval · 2009-10-14FDA Approved: TOPIRAMATE — Original Application (Zydus Lifesciences Limited)
FDA approved the original application for Topiramate from Zydus Lifesciences Limited, indicating regulatory approval of a generic Topiramate…
-
CLINICAL_TRIALS trial_result · 2009-10-06Clinical Trial Update: Study of Valproate in Young Patients Suffering From Epilepsy [Phase 4]
The trial update reports completion of a Phase 4 study evaluating valproate in young patients with epilepsy.
-
FDA approval · 2009-09-30FDA Approved: TOPIRAMATE — Supplemental Application (Cipla USA Inc.)
FDA approved a supplemental application for Topiramate from Cipla USA Inc., reflecting an approved supplemental change to a previously autho…
-
CLINICAL_TRIALS trial_result · 2009-09-23Clinical Trial Update: Levetiracetam Treatment of Children With Subclinical Sleep-Activated Epileptiform Activity (SSEA) [Phase 4]
Phase 4 clinical trial update evaluating levetiracetam for children with Subclinical Sleep-Activated Epileptiform Activity and CSWS. The cur…
-
FDA approval · 2009-09-22FDA Approved: LAMOTRIGINE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for lamotrigine from Aurobindo Pharma Limited.
-
FDA approval · 2009-09-21FDA Approved: LAMOTRIGINE KIT — Supplemental Application (OWP Pharmaceuticals, Inc.)
FDA approves a supplemental application for the Lamotrigine Kit from OWP Pharmaceuticals, Inc. under ANDA078947, confirming the continued av…
-
FDA approval · 2009-09-21FDA Approved: LAMOTRIGINE — Supplemental Application (Dr.Reddy's Laboratories Limited)
FDA approved a supplemental application for lamotrigine filed by Dr. Reddy's Laboratories Limited.
-
FDA approval · 2009-09-21FDA Approved: LAMOTRIGINE — Supplemental Application (Dr.Reddy's Laboratories Limited)
The FDA approved a supplemental application for Lamotrigine by Dr. Reddy's Laboratories Limited, updating an existing Lamotrigine product. T…
-
FDA approval · 2009-09-15FDA Approved: LEVETIRACETAM — Supplemental Application (Patrin Pharma, Inc.)
The FDA approved a supplemental application for the generic anticonvulsant levetiracetam from Patrin Pharma, Inc. (ANDA078582).
-
CLINICAL_TRIALS trial_result · 2009-09-02Clinical Trial Update: A Multicenter Comparative Trial of Zonisamide and Topiramate as Initial Monotherapy in Untreated Epilepsies [Phase 4]
A Phase 4 multicenter trial comparing zonisamide and topiramate as initial monotherapy in untreated epilepsy has completed.
-
FDA approval · 2009-08-24FDA Approved: LEVETIRACETAM — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for LEVETIRACETAM by Sun Pharmaceutical Industries, Inc., updating labeling based on the submission.…
-
FDA approval · 2009-08-20FDA Approved: LEVETIRACETAM SOLUTION — Supplemental Application (Chartwell RX, LLC)
The FDA approved a supplemental application to add a levetiracetam solution dosage form (generic) under Chartwell RX, LLC.
-
CLINICAL_TRIALS trial_result · 2009-08-20Clinical Trial Update: Trial of Levetiracetam in Patients With Primary Brain Tumors and Symptomatic Seizures Who Undergo Surgery [Phase 4]
Phase 4 trial update showing study on levetiracetam for seizures in patients with primary brain tumors undergoing surgery; the trial status …
-
CLINICAL_TRIALS research · 2009-08-11Clinical Trial Update: Topiramate Treatment for Patients With Epilepsy and Learning Disability : A Prospective Observational Study
A prospective observational study evaluating topiramate use in patients with epilepsy and learning disability; no regulatory approval result…
-
FDA approval · 2009-08-04FDA Approved: DIVALPROEX SODIUM — Supplemental Application (BluePoint Laboratories)
FDA has approved a supplemental application for divalproex sodium from BluePoint Laboratories.
-
FDA approval · 2009-07-31FDA Approved: LEVETIRACETAM — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approved a supplemental application for levetiracetam from Dr. Reddy's Laboratories Limited.